Moving goalposts--regulatory oversight of antibacterial drugs.
Is uncertainty concerning the regulation of antimicrobial drug trials stifling investment in infectious disease treatments? Here, experts from a large pharma company and a biotech firm provide their perspectives.
Brenner
Randall
R
Wyeth Pharmaceuticals, 500 Arcolo Road, Collegeville, Pennsylvania 19426, USA. brenner1@wyeth.com
Ellis-Grosse
Evelyn J
EJ
Echols
Roger
R
D000900:Anti-Bacterial Agents / Q000096:biosynthesis / Q000138:chemical synthesis; D001709:Biotechnology / Q000331:legislation & jurisprudence*; D002986:Clinical Trials as Topic / Q000592:standards*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D008826:Microbial Sensitivity Tests / Q000379:methods; D014481:United States
D000900:Anti-Bacterial Agents